Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
Health & Research Topics
>
Biodefense and Related Programs
>
Chemical Countermeasures
>
Research Areas
>
Nervous System
Skip Website Tools
Website Tools
Email this page
Print this page
Get email updates
Get plug-ins and viewers
Order publications
Skip Stay Connected
Stay Connected
Additional Information From NIAID
Resources for Researchers
NIH Strategic Plan and Research Agenda for Medical Countermeasures Against Chemical Threats
(PDF 3 MB)
Biodefense and Emerging Infectious Diseases
—The NIAID Biodefense website includes biodefense-related information for biomedical researchers, the public, and the media.
External Resources
National Institute of Neurological Disorders and Stroke
National Institute of Environmental Health Sciences
View a list of links
for more information about Medical Countermeasures Against Chemical Threats
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
Medical Countermeasures Against Chemical Threats
Skip Content Marketing
Share this:
Nervous System
Long-Term Goals
Expand knowledge of the mechanisms by which chemical agents affect the nervous system and its neuroexcitatory pathways
Expand knowledge of the physiological responses to toxic chemicals, including oxidative stress, at the cellular and molecular levels, and the inflammatory changes and other immune responses following chemical exposure
Identify mechanisms and types of injury and recovery associated with specific nerve agents and the anti-seizure responses to anticonvulsants
Identify any differences in the susceptibility of different civilian populations to the toxic effects of nerve agents
Determine the applicability and safety of specific medical countermeasures to different subpopulations in the United States, to include those with pre-existing illnesses or taking other medications
Identify acute and chronic neurological effects of exposure to high and low levels of chemical agents and strategies for intervention
Identify new rapid screening techniques or diagnostic tools that can be used in the evaluation of individuals during and following suspected chemical exposure
Identify biomarkers of injury to help identify the specific chemicals responsible for observed neurological symptoms
Support technologies used in portable assessment devices that could prove useful in the initial evaluation and treatment of chemically induced seizures during a mass casualty situation
Evaluate different safe and effective routes of administration of FDA-approved anticonvulsants and other drugs
Develop new enzyme reactivators that are broadly effective against groups of nerve agents, including those agents, such as soman, that make the body refractory to treatment over time
Develop bioscavengers that can break down nerve agents into inert substances
Evaluate approaches to eliminate and/or deactivate nerve agents from body surfaces and open wounds to prevent further absorption, exposure, and injury
Develop appropriate animal models of acute and chronic chemically induced neurological injury that parallel the human experience
Establish databases of clinical, epidemiological, and laboratory information that will contribute to the understanding of the mechanisms of nerve agent-induced injury, and the acute and chronic effects of high and low level exposure
back to top
Last Updated February 29, 2008